• A unique collection of 2698 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).
• The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).
• Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure, IC50, and customer reviews.
• NMR and HPLC validated to ensure high purity.
• All compounds are in stock and continuously updated.